SINGAPORE: Singapore Exchange (SGX) and the Intellectual Property Office of Singapore (IPOS) have partnered to launch the Intangible Disclosure Evaluation and Audit Scheme (IDEAS) programme exclusively for SGX-listed companies and companies preparing for a listing.

The programme aims to raise awareness and encourage companies to undergo intangible assets (IA) evaluations and promote a more robust IA disclosure environment. This will help investors better appreciate the value of intangible assets, and support companies in capital raising.

In a knowledge-driven economy, IA is becoming increasingly critical in enterprise growth and success. Empirical evidence shows leading global technology companies are investing heavily into IA[1] to remain competitive. Despite this evidence, important IA information is often omitted from financial and stakeholder reports, which remain rooted in traditional accounting practices developed for a production-based economy.

The IDEAS programme provides companies with government support to undergo an IA evaluation and audit process. The process will enable companies to identify important IA information that are key drivers to their businesses, and make recommendations on disclosing such important information to communicate business value to the market.

Greater transparency and clarity in IA disclosures will help companies build investor trust and enhance the effectiveness of Singapore capital market in helping IA-rich businesses raise capital as the knowledge economy shifts away from the traditional indicators of performance grounded in tangible asset values.

Mr Chew Sutat, Head of Global Sales and Origination at SGX, said, “Our partnership with IPOS is another step towards our vision of creating a robust and supportive ecosystem in Singapore for innovative companies. Listing on the exchange is often one of the steps in a company’s journey and we are committed to supporting businesses through every phase of their growth. In helping to develop greater awareness and understanding of IA, we can bring more value to our listed companies and the wider business community.”

Dr Bernard Ong, Group Director of Policy & Engagement at IPOS, said: “Technologies, brands, ideas, data, know-hows and other forms of IA are the primary forces making the world’s most innovative and valuable enterprises. Yet, market understanding of IA, including intellectual property, remains a big challenge to investors and enterprises alike. IDEAS will enable investors to make sharper investment decisions while helping IA rich companies unleash their real enterprise value. IPOS is delighted to partner with SGX to nurture and grow the next frontier of innovative enterprises for Singapore.”

IDEAS will run as a pilot programme until the end of 2020. During this period, companies will be nominated by SGX and IPOS to participate in the programme and will receive IPOS’ support to undergo an evaluation to identify key IA information that could be better disclosed to their stakeholders.  Feedback gathered during the pilot phase will be instrumental in shaping future support for IA disclosures. Only a limited number of companies will be able to participate in the pilot programme.

SGX-listed companies, REVEZ Corporation Ltd and Hyphens Pharma International Limited, as well as Memiontec, currently preparing for its listing, are some of the companies already confirmed to join the IDEAS programme.

Mr Victor Neo, Deputy Board Chairman and Group CEO of Revez Corporation Ltd said, “REVEZ is glad to participate in IDEAS. It is a good opportunity for the company to identify and articulate our business value that is driven by non-physical and non-monetary assets, such as our reputation, expertise and brand value. I am confident that after going through IDEAS, REVEZ will have valuable IA information to better communicate our position as a leading innovator in our industry. It will provide greater confidence of the long-term prospects of our company to clients, investors and potential partners.”

Ms Fang Lee Wei, Chief Financial Officer at Hyphens Pharma International Limited, said, “We are excited by the opportunity to join the IDEAS programme. As ASEAN’s leading specialty pharma and consumer healthcare group, Hyphens possesses a considerable portfolio of intangible assets that not only differentiates us from competitors but is also a vital source of competitive advantage to drive sustainable growth. We hope that through IDEAS, our investors can better recognise the long-term value of our business.”

Mr Tay Kiat Seng, CEO of Memiontec said, “We believe that our participation in IDEAS will provide us with fresh insights on the value drivers of our business. Having a deeper understanding of our company’s intangible asset and proprietary know-how, can enhance how we showcase our value to our clients and investors”.